How We Work

The Solutions Approach

Determining the carrier status for individuals at risk of a genetic disease can have immense impact on management of care.

Genetic predisposition can be determined soon after conception, but clinical symptoms may not be observed for years, and often after a catastrophic health event. Consequently, conventional care without genetic tests often requires invasive and expensive clincal screening exams to guard against the possibility of disease.

Accessible, quick and reliable, genetic analysis provides clinicians with an extremely powerful tool to manage the effects of genetic predisposition. Moreover, genetic analysis has been shown in some circumstances to reduce the overall cost of care by making clinical screening exams unnecessary for the majority of individuals otherwise at risk.

Widespread clinical implementation of genetic analysis has been slow, however, for several reasons. To change clinical care, referring clinicians first must have high confidence in the results and interpretation of molecular assays. Clinicians who have disease-specific expertise do not always have genetics knowledge sufficient to allow them to remove a patient from screening exams on the basis of molecular analysis alone. Clinicians need expert assistance.

Solutions by Sequence seeks to be a partner in care to referring clinicians. In contrast to general service molecular diagnostic labs, our company creates teams of molecular biologists with deep disease-specific expertise. Such teams perform extremely reliable "reference lab" assays and write clear, thorough analysis for clinical patners.

For more info, please phone us at 416-603-5597.  We are always enthusiastic about talking with clients, colleagues and investors.